期刊文献+

不同水碘地区甲状腺肿瘤患者血清促甲状腺激素观察 被引量:2

The differences in serum thyroid-stimulating hormone levels of patients with thyroid tumors in the areas with different iodine levels in drinking water
原文传递
导出
摘要 目的观察不同水碘地区甲状腺肿瘤患者血清促甲状腺激素(TSH)水平,探讨血清TSH水平在甲状腺肿瘤诊断中的意义。方法采用生态学研究方法,在山东省菏泽市所属单县、曹县、牡丹区3个县区的医院.收集甲状腺肿瘤患者的病历资料.包括一般情况、血清TSH水平、病理报告等。利用水碘监测数据对病历患者所在地区进行分类,并按照病理报告分为甲状腺癌患者和良性肿瘤(非甲状腺癌)患者,比较其血清TSH水平:按血清偈H水平(〈0.38、0.38-1.50、〉1.50~2.50、〉2.50-5.57、〉5.57mU/L)分组,分析甲状腺癌患者构成;采用Spearman等级相关分析水碘与甲状腺肿瘤患者TSH水平的相关性。结果甲状腺癌患者(n=190)血清,TSH的中位数(M)为2.55mU/L,范围为(0.10~20.46)mU/L,显著高于非甲状腺癌患者[n=549,M=2.24mU/L,范围为(0.01,24.90)mU/L],二者比较差异有统计学意义(Z=-2.33,P〈0.05)。按血清r11SH水平(〈0.38、0-38~1.50、〉1.50~2.50、〉2.50。5.57、〉5.57mU/L)分组,甲状腺癌患者构成比有随着TSH水平的增加而升高的趋势,分别为21.6%(8/37)、21.2%(39/184)、25.8%(46/178)、27.8%(64/230)和30.4%(34/112),但组间比较,差异无统计学意义(x2=4.086,P〉0.05)。水碘与甲状腺肿瘤患者血清TSH水平间存在正相关关系[相关系数(k)=0.539,P〈0.05]。结论在水源性高碘地区,甲状腺肿瘤患者术前血清中aSH水平对于诊断甲状腺良恶性肿瘤具有参考价值。 Objective We investigated serum thyroid-stimulating hormone (TSH) concentrations in patients who had been diagnosed thyroid tumors in areas with different iodine levels in drinking water. We evaluated the significance of serum TSH levels in thyroid tumors. Methods An ecological study of patients from Heze Municipal Hospital, Shanxian Central Hospital and Caoxian People's Hospital was implemented. Variables included age at diagnosis, gender, TSH level, final histology (benign versus cancer), and iodine concentrations in the drinking water. We compared the serum TSH levels of patients with benign and malignant thyroid tumors. The patients were divided into 5 groups based on serum TSH ( 〈 0.38, 0.38 - 1.50, 〉 1.50 - 2.50, 〉 2.50 - 5.57, and 〉 5.57 mU/L), and we analyzed the constituent ratio of patients with thyroid cancer. We analyzed the correlation between serum TSH levels of patients with thyroid cancer and iodine concentrations in the drinking water by the statistical method of Spearman rank correlation. Results Thyroid cancer patients (n = 190) had higher serum TSH levels [2.55 (0.10 - 20.46) mU/L vs 2.24 (0.01 - 24.90) mU/L, Z = - 2.33, P 〈 0.05] as compared to those with no malignancy (n = 549). The patientswere divided into 5 groups of patients each based on serum TSH: 〈 0.38, 0.38 - 1.50, 〉 1.50 - 2.50, 〉 2.50 - 5.57 and 〉 5.57 mU/L; the constituent ratio of malignant tumor increased with increasing TSH concentration, with respective rates of 21.6% (8/37), 21.2% (39/184), 25.8% (46/178), 27.8% (64/230), and 30.4% (34/112)in the 5 groups, but there was no significant difference (X2 = 4.086, P 〉 0.05). There was a positive correlation between serum TSH levels of patients and iodine in drinking water (rs = 0.539, P 〈 0.05). Conehlsion Our study has supported an association between preoperative TSH levels and risk of malignant tumors in patients who had been diagnosed thyroid tumors in areas with high water iodine levels.
出处 《中华地方病学杂志》 CAS CSCD 北大核心 2016年第8期557-560,共4页 Chinese Journal of Endemiology
基金 卫生部行业基金(201202012)National Health Scientific Research in the Public Interest by the Ministry of Health of China
关键词 饮水 流行病学 促甲状腺激素 甲状腺肿瘤 Drinking water Iodine Epidemiology Thyroid-stimulating hormone Thyroid tumors
  • 相关文献

参考文献20

  • 1Nix P, Nicolaides A, Coatesworth AP. Thyroid cancer review 1: presentation and investigation of thyroid cancer[J]. Int J Clin Pract,2005,59(11): 1340-1344.
  • 2郝伟伟,栗夏莲.血清TSH水平与甲状腺肿瘤良恶性关系的研究[J].河南医学研究,2013,22(2):161-164. 被引量:7
  • 3Polyzos SA, Kita M, Efstathiadou Z, et al. Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules[J]. J Cancer Res Clin Oncol,2008,134(9):953-960.
  • 4Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States,1973-2002[J]. JAMA,2006,295(18):2164-2167.
  • 5Vejbjerg P, Knudsen N, Perrild H, et al. Lower prevalence of mild hyperthyroidism related to a higher iodine intake in the population: prospective study of a mandatory iodization programme[J]. Clin Endocrinol(Oxf),2009,71(3):440-445.
  • 6Cooper DS, Doherty GM, Haugen BRo et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer[J]. Thyroid,2006,16(2):109-142.
  • 7Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer [J]. Thyroid, 2009,19(11):1167-1214.
  • 8Bulow PI, Knudsen N, Jorgensen T, et al. Large differences in incidences of overt hyper-and hypothyroidism associated with a small difference in iodine intake: a prospective comparative register-based population survey [J]. J Clin Endocrinol Metab, 2002,87(10):4462-4469.
  • 9Fiore E, Vitti P. Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease[J]. J Clin Endoerinol Metab,2012,97 (4):1134-1145.
  • 10Du Y, Gao Y, Meng F, et al. Iodine deficiency and excess coexist in china and induce thyroid dysfunction and disease: a crosssectional study[J]. PLoS One,2014,9(11):e111937.

二级参考文献19

  • 1Davies L, Welch H G. Increasing incidence of thyroid cancer in the U- nited States, 1973-2002 [ J ]..lAMA,2006,295 ( 18 ) :2164-2167.
  • 2Hermus A R, Huysmans D A. Treatment of benign nodular thyroid dis-ease [ J]. N EngI J Med, 1998,338 (20) : 1438-1447.
  • 3Mazzaferri E L,Jhiang S M. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer[J]. Am J Med,1994,97 (5) :418-428.
  • 4Boelaert K, Horacek J, Holder R L,et al. Serum thyrotropin concen- tration as a novel predictor of malignancy in thyroid nodules investiga- ted by fine-needle aspiration [ J]. Clinical Endocrinology & Metabo- lism ,2006,91 ( 11 ) :4295-4301.
  • 5Haymart M R, Repplinger D J, Leverson G E, et al. Higher serum TSH level in thyroid nodule patients is associated with greater risks of dif- ferentiated thyroid cancer and advanced tumor stage [ J ]. Journal of Clinical Endocrinology&Metabolism, 2007,93 ( 3 ) : 809-814.
  • 6McLeod D S,Watters K F,Carpenter A D, et al. Serum TSH levels in the upper normal range suggest that a thyroid nodule is malignant [ J ]. Clin Endocrinol Metab,2012,97 (8) :2682-2692.
  • 7Polyzos S A,Kita M,Efstathiadou Z,et al. Serum thyrotropin concen- tration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules [ J ]. Cancer Res Clin Onco1,2008,134 (2) :953-960.
  • 8Raber W, Kaserer K, iederle B, et al. Risk factors for malignancy of thyroid nodules initially identified as follicular neoplasia by fine needleaspiration : results of a prospective study of one hundred twenty patients[J ]. Thyroid, 2000,10 ( 2 ) : 709-712.
  • 9Hegedus L, Bonnema S J, Bennedbaek F N. Management of simple nodular goiter:current status and future perspectives[ J]. Endoer Rev, 2003,24 ( 11 ) : 102-132.
  • 10Raparia K,Min S K, Mody D R, et al. Clinical outcomes for " suspi- cious" category in thyroid fine-needle aspiration biopsy:patient' s sex and nodule size are possible predictors of malignancy[ J]. Arch Pathol Lab Med ,2009,133 ( 17 ) :787-790.

共引文献6

同被引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部